Fundz

Imidomicstm Closes $16.5 Million Series A Financing To Advance Its Precision Discovery Platform For Immune-Mediated Inflammatory Diseases

PRIVATEJul 27, 2021

Amount Raised

$16.5 Million

Round Type

Series A

San RafaelOtherMedia And Entertainment

Investors

Pritzker Group

Description

IMIDomics Inc., a drug discovery company focused on patients with immune-mediated inflammatory diseases (IMIDs), has announced the completion of a $16.5 million Series A financing round. The round was led by DNS Capital with additional investment from Bristol Myers Squibb, The Pritzker Organization, Tao Capital and others. IMIDomics was founded in 2015, following a decade of incubation within Vall d’Hebron Hospital in Barcelona, during which the IMID-Biobank was built. The company relocated to the United States in 2021.

Who to call at IMIDomics, and when

A new round usually means IMIDomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IMIDomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IMIDomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IMIDomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IMIDomics

Location

San Rafael, California, United States

About

IMIDomics was founded in Barcelona, Spain in 2015 by Dr. Sara Marsal, Head of the Rheumatology Department at the Vall d’Hebron University Hospital, and Dr. Richard M. Myers, President and Scientific Director at the HudsonAlpha Institute for Biotechnology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IMIDomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for IMIDomics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

IMIDomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.